Case45 Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
6
Case45 General Information
Description
Developer of novel pan-cancer precision biomarkers designed to prognosticate and tailor therapies for patients. The company offers a generalizable AI engine that integrates various medical data with tissue images by assessing immune responses within tumor ecosystems, enabling doctors to stay ahead of cancer, prescribe optimized treatments, and ultimately defeat it.
Contact Information
Website
www.case45.comCorporate Office
- 5 Beaconsfield Street
- King's Cross
- London N1C 4EW
- England, United Kingdom
Corporate Office
- 5 Beaconsfield Street
- King's Cross
- London N1C 4EW
- England, United Kingdom
Case45 Timeline
Case45 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 01-Aug-2026 | Completed | Startup | |||
| 4. Early Stage VC | 01-Mar-2025 | Completed | Startup | |||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | 01-Jan-2024 | $10.6K | Completed | Startup | ||
| 1. Accelerator/Incubator | 01-Jan-2023 | $10.6K | $10.6K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Case45 Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Case45 Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Case45 Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MBX Capital | Venture Capital | Minority | ||
| Modi Ventures | Venture Capital | Minority | ||
| Verve Ventures | Venture Capital | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator | |||
| Enterprise Hub - Royal Academy of Engineering | Accelerator/Incubator |
Case45 FAQs
-
When was Case45 founded?
Case45 was founded in 2022.
-
Where is Case45 headquartered?
Case45 is headquartered in London, United Kingdom.
-
What is the size of Case45?
Case45 has 3 total employees.
-
What industry is Case45 in?
Case45’s primary industry is Other Healthcare Technology Systems.
-
Is Case45 a private or public company?
Case45 is a Private company.
-
What is Case45’s current revenue?
The current revenue for Case45 is .
-
How much funding has Case45 raised over time?
Case45 has raised $10.6K.
-
Who are Case45’s investors?
MBX Capital, Modi Ventures, Verve Ventures, Creative Destruction Lab, and Enterprise Hub - Royal Academy of Engineering are 5 of 6 investors who have invested in Case45.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
